Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-20.27	-371.84	-309.16
Graham Fair Price	-11.14	3.50	3.93
PEG	0.86	5.32	5.27
Price/Book	24.84	6.70	5.37
Price/Cash Flow	150.20	285.20	113.99
Prices/Earnings	-66.27	-134.88	-81.12
Price/Sales	26.15	47.28	37.47
Price/FCF	150.20	285.20	113.99
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.11	0.79	0.79
Operating Margin	-3.49	-0.16	-0.16
ROA	23.67	< 0.005	-0.01
ROE	-0.02	-0.01	24.92
ROIC	-0.03	-0.02	24.40
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.11	-0.08	-40.41
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.15	-0.07	-54.49
EPS QOQ	0.15	0.25	64.86
FCF QOQ	0.26	-0.48	85.06
Revenue QOQ	0.10	0.03	-67.76
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	50.14	< 0.005	-100.00
Days Sales Outstanding (DSO)	70.73	59.73	-15.56
Inventory Turnover	1.79	10489000.00	584359896.08
Debt/Capitalization	0.03	0.03	-13.96
Quick Ratio	2.37	2.48	4.76
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.45	6.61	2.55
Cash	5.18	5.42	4.65
Capex	< 0.005	< 0.005	-33.90
Free Cash Flow	0.30	0.16	-48.83
Revenue	0.92	0.94	1.48
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.46	2.55	3.55
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.40	4.09	-24.28
Naive Interpretation	Member

06 - Financial Health · Bad

Rating